The study “ The Amazing and Mighty Ginger “ by Bode et al. (2011) is a book chapter from the second edition of Herbal Medicine: Biomolecular and Clinical Aspects. Bode and Dong, both cancer researchers, pulled together hundreds of studies on ginger and its compounds. They cover history, chemistry, metabolism, and health effects. The chapter is among the most-cited overviews of ginger's benefits in the scientific literature, and the authors offer a fairly balanced view: some uses are well supported; others are not

Ginger (Zingiber officinale Roscoe) is the root of a plant in the same family as turmeric and cardamom. People have used it as food and folk medicine for over 3,000 years. The authors note that in medieval Europe, “the value of a pound of ginger was equivalent to the cost of a sheep.” India is now the world’s largest producer.

The most studied compound in ginger is 6-gingerol. When ginger dries, its gingerols convert to shogaols, which are often more active. Scientists have identified at least 115 compounds in ginger, of which at least 14 are considered bioactive. The authors point out a real problem with ginger supplements: one study found that the active compound content “was found to vary extensively from none or very minute amounts to several milligrams per gram.” That makes consistent dosing very hard.

This is a narrative review, not new lab work. Bode and Dong gathered findings from prior studies on ginger’s chemistry, metabolism, and health effects. They organized the evidence by area: antioxidant action, inflammation, nausea, cancer, and heart disease. They include both lab studies and human trials, but they do not use a formal scoring system to rate study quality.

Ginger ranks high among foods for antioxidant content. The authors note ginger root “contains a very high level (3.85 mmol/100 g) of total antioxidants, surpassed only by pomegranate and some types of berries.” Compounds such as 6-gingerol can reduce nitric oxide (NO) production and protect cells from oxidative stress in laboratory models. Animal studies show ginger protects organs against damage from chemicals, alcohol, and radiation.

The catch: “whether the physiological activity occurs in humans in vivo is not clear, and the specific mechanism and cellular targets are still to be determined.” That is an important, honest note from the authors.

Ginger compounds appear to block enzymes involved in inflammation, including cyclooxygenase-2 (COX-2) and 5-lipoxygenase. They also reduce inflammatory signals, such as tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β). In one clinical trial cited in the chapter, ginger capsules (250 mg) “were as effective as the nonsteroidal anti-inflammatory drugs mefenamic acid (250 mg) and ibuprofen (400 mg) in relieving pain in women with primary dysmenorrhea” (painful periods).

Results for arthritis are mixed. Some studies show that ginger helps knee osteoarthritis. Others show no difference from placebo. One pre-exercise ginger trial found no effect on cycling-induced muscle pain, contradicting the muscle pain finding I mentioned in the earlier 2013 paper review. The authors are clear: “the data supporting ginger as an effective anti-inflammatory agent in humans in vivo are still contradictory and incomplete.”

This is the strongest part of the chapter. The authors call nausea relief “the most common and well-established use of ginger throughout history.” Multiple controlled trials show ginger:

• Helps with morning sickness in pregnancy without raising the rate of birth defects.
• Works about as well as vitamin B6 for pregnancy nausea (some trials show ginger does better).
• May help with post-surgery nausea (a meta-analysis found that at least 1 g of ginger beats placebo).
• Has mixed results for chemotherapy-related nausea, with some trials showing no extra benefit when added to standard antiemetic drugs.

The authors quote a systematic review showing ginger “is superior to placebo and as effective as vitamin B6 in relieving the severity of nausea and vomiting, with no reported side effects or adverse effects on pregnancy.” They conclude that “ginger appears to have no adverse side effects and never seems to worsen nausea and vomiting.”

This is the authors’ area of research. They explain that ginger compounds can:

• Block cell growth in many cancer cell lines (skin, colon, breast, ovarian, prostate, liver, pancreatic).
• Trigger cancer cell death (apoptosis) through caspase activation.
• Block tumor blood vessel growth (angiogenesis).
• Lower nuclear factor of kappa light chain enhancer (NF-κB) signaling is associated with tumor growth.

Importantly, the authors report their own work identifying a direct protein target: “6-gingerol suppresses anchorage-independent cancer cell growth by binding to LTA4H and inhibiting LTA4H activity in HCT116 colorectal cancer cells.” This is more specific than most ginger-cancer claims.

One cautionary finding: in one bladder cancer model in mice, “ginger extract was not able to inhibit the development” of cancer, and “the incidence of grade 2 transitional cell carcinoma was increased.” Ginger is not universally protective.

A double-blind human trial found that 3 g of ginger powder daily “significantly lowered lipid levels,” including triglycerides, cholesterol, and LDL (“bad” cholesterol), while raising HDL (“good” cholesterol). Animal studies show similar effects on diabetes markers, with one rat study finding that ginger improved glucose tolerance and insulin levels.

The U.S. Food and Drug Administration (FDA) classifies ginger as “ generally recognized as safe.” Animal studies up to 2000 mg/kg for 35 days showed no major harm. Human pregnancy studies showed no increase in birth defects from ginger.

There are real concerns to be aware of. Ginger may increase the risk of bleeding after surgery or with blood thinners like warfarin, though the evidence is mixed. One historical note from the chapter: in 1930, an adulterated “Jamaican ginger” extract poisoned thousands of Americans, but the toxin was a separate chemical, not ginger itself.

The chapter’s most useful conclusion is that ginger benefits vary widely by use. For nausea, especially in pregnancy, the evidence is strong enough that many obstetricians recommend it. For inflammation, painful periods, and lipid levels, there is decent human evidence. For arthritis, cancer prevention, and diabetes, the evidence is mostly preclinical, and people should not rely on ginger as a treatment.

The authors close with this: “Ginger has been reported to possess diverse pharmacological properties, although its specific biological targets are largely unknown and remain to be determined.”

A 2011 review of ginger benefits by cancer researchers Bode and Dong shows that ginger is well supported for nausea, especially during pregnancy, surgery, and possibly chemotherapy. Anti-inflammatory and heart benefits look promising, but need more solid human trials. Cancer claims remain mostly lab-based. Ginger appears safe at normal doses, but supplement quality varies widely. For everyday use, ginger tea or ginger in food is a reasonable, low-risk choice. For treating a disease, talk to a doctor first.